ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κB.
about
IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkersTargeting the PDGF signaling pathway in tumor treatmentAntitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cellsTRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemiaCytokines in radiobiological responses: a review.NFκB signaling regulates embryonic and adult neurogenesis.World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.PDGF-induced fibroblast growth requires monounsaturated fatty acid production by stearoyl-CoA desaturase.The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations.The expression of the tumour suppressor HBP1 is down-regulated by growth factors via the PI3K/PKB/FOXO pathway.World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.
P2860
Q33940685-EE6300A5-0F33-469D-BCD4-0FE9EF8BF25EQ34326409-C3BBD485-3F66-49EC-8CC9-F7096CAA8809Q34393461-922B4C4C-1785-4FDA-8201-38C3B5EE08D2Q34786462-D8278638-3D90-49A6-9907-1C87BEBDC229Q34986164-5C3F1C74-A66F-4EAC-AB5B-E735A1E5EF85Q37045283-82B54A4A-BC00-4F90-A0BF-8626BDD7C908Q37373888-15F99FE2-A3A7-4FDF-9C4D-52A53C53888DQ38038509-34F2DCAF-1CDB-414D-9133-61F5962BA42EQ38131481-EDE869D1-3FFD-4A82-A115-F824917F1407Q38177821-C35A61A2-9CB9-43F3-A70C-B930089FCD25Q38191834-9107D5D7-DEE8-4762-8F0A-88998ABC5EDBQ38911952-7ADF31F8-5E30-4F65-B273-D8889516752FQ39016533-22728CFA-C819-46E2-88F9-AF988B9D5BB6Q39141642-1ECF3FD4-D438-4AA4-AC2A-D5B25C8503CDQ42803561-2001E8A9-1AED-458D-859B-32EB3335CD52Q46026437-960C3D65-5890-4003-ACBD-8500A2690CEFQ46476524-38C2263D-9949-4F54-BC1F-B950883E4144
P2860
ETV6-PDGFRB and FIP1L1-PDGFRA stimulate human hematopoietic progenitor cell proliferation and differentiation into eosinophils: the role of nuclear factor-κB.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@en
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@nl
type
label
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@en
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@nl
prefLabel
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@en
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@nl
P2093
P2860
P1433
P1476
ETV6-PDGFRB and FIP1L1-PDGFRA ...... the role of nuclear factor-κB.
@en
P2093
Ahmed Essaghir
Amélie I Velghe
Carmen P Montano-Almendras
Dominique Latinne
Hélène Schoemans
Inci Varis
Laura A Noël
Laurent Knoops
P2860
P304
P356
10.3324/HAEMATOL.2011.047530
P577
2012-01-22T00:00:00Z